Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ZBIOZBIO
5 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ZENAS BIOPHARMA INC

GOLDMAN SACHS GROUP INC holds 381,461 shares of ZBIO (ZENAS BIOPHARMA INC), worth $7.5M as of 2026-Q1. The position was increased (+191.9% shares). ZBIO represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$7.5M

Current Shares

381,461

Total Value Change

+$7.1M

Total Shares Change

+339,287

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
381,461
+191.9%
$7.5M0.0%$25.18
44
2025-Q4
New
130,698
-
$4.7M0.0%$36.58
37
2025-Q2
Exited
0
-100.0%
$00.0%$9.58
0
2025-Q1
Decreased
23,957
-43.2%
$189,2600.0%$8.17
0
2024-Q4
New
42,174
-
$345,4050.0%$8.99
33

Other major holders of ZBIO: FMR LLC, FEDERATED HERMES, INC., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used